JPS5555200A - Steroid compound and medicine composition - Google Patents
Steroid compound and medicine compositionInfo
- Publication number
- JPS5555200A JPS5555200A JP13126279A JP13126279A JPS5555200A JP S5555200 A JPS5555200 A JP S5555200A JP 13126279 A JP13126279 A JP 13126279A JP 13126279 A JP13126279 A JP 13126279A JP S5555200 A JPS5555200 A JP S5555200A
- Authority
- JP
- Japan
- Prior art keywords
- medicine composition
- steroid compound
- steroid
- compound
- medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
- C07J71/0073—Sulfur-containing hetero ring
- C07J71/0078—Sulfur-containing hetero ring containing only sulfur
- C07J71/0084—Episulfides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
- C07J1/0003—Androstane derivatives
- C07J1/0018—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa
- C07J1/0022—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
- C07J1/0003—Androstane derivatives
- C07J1/0018—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa
- C07J1/0022—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
- C07J1/0029—Ethers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
- C07J1/0003—Androstane derivatives
- C07J1/0033—Androstane derivatives substituted in position 17 alfa and 17 beta
- C07J1/0037—Androstane derivatives substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being a saturated hydrocarbon group
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
- C07J1/0003—Androstane derivatives
- C07J1/0033—Androstane derivatives substituted in position 17 alfa and 17 beta
- C07J1/004—Androstane derivatives substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being an unsaturated hydrocarbon group
- C07J1/0048—Alkynyl derivatives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
- C07J21/005—Ketals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
- C07J21/005—Ketals
- C07J21/006—Ketals at position 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0005—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring the nitrogen atom being directly linked to the cyclopenta(a)hydro phenanthrene skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0005—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring the nitrogen atom being directly linked to the cyclopenta(a)hydro phenanthrene skeleton
- C07J41/0016—Oximes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
- C07J53/001—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class spiro-linked
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
- C07J53/002—Carbocyclic rings fused
- C07J53/004—3 membered carbocyclic rings
- C07J53/005—3 membered carbocyclic rings in position 12
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
- C07J71/0005—Oxygen-containing hetero ring
- C07J71/001—Oxiranes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
- C07J71/0036—Nitrogen-containing hetero ring
- C07J71/0042—Nitrogen only
- C07J71/0047—Nitrogen only at position 2(3)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
- C07J71/0036—Nitrogen-containing hetero ring
- C07J71/0057—Nitrogen and oxygen
- C07J71/0063—Nitrogen and oxygen at position 2(3)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
- C07J71/0073—Sulfur-containing hetero ring
- C07J71/0094—Sulfur-containing hetero ring containing sulfur and nitrogen
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US05/949,797 US4297350A (en) | 1978-10-10 | 1978-10-10 | Male contraceptive steroids and methods of use |
Publications (1)
Publication Number | Publication Date |
---|---|
JPS5555200A true JPS5555200A (en) | 1980-04-22 |
Family
ID=25489549
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP13126279A Pending JPS5555200A (en) | 1978-10-10 | 1979-10-11 | Steroid compound and medicine composition |
Country Status (8)
Country | Link |
---|---|
US (1) | US4297350A (ja) |
JP (1) | JPS5555200A (ja) |
CH (1) | CH643565A5 (ja) |
DE (1) | DE2940132A1 (ja) |
FR (1) | FR2438663A1 (ja) |
GB (1) | GB2032924B (ja) |
IT (1) | IT1124568B (ja) |
NL (1) | NL7907317A (ja) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0648501A (ja) * | 1992-06-04 | 1994-02-22 | Chichibu Cement Co Ltd | 有害物処理容器 |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4684636A (en) * | 1985-06-24 | 1987-08-04 | Sterling Drug Inc. | Antiandrogenic sulfonylsteroidopyrazoles and processes for preparation method of use and compositions thereof |
US5134135A (en) * | 1990-06-21 | 1992-07-28 | Sterling Drug Inc. | Antiandrogenic sulfonylsteroidooxazoles |
DE4021433A1 (de) * | 1990-07-04 | 1992-01-09 | Schering Ag | Antiandrogene mit steroid(3,2-c)pyrazol-struktur |
WO1993007749A1 (en) * | 1991-10-23 | 1993-04-29 | Akzo Nobel N.V. | Pest control compositions |
IL105050A0 (en) * | 1992-03-27 | 1993-07-08 | Lilly Co Eli | Steroid derivatives |
JPH06218028A (ja) * | 1992-10-02 | 1994-08-09 | Eisai Co Ltd | 湿製錠の成型方法とその装置及び湿製錠 |
HUP9901138A3 (en) * | 1995-06-06 | 1999-11-29 | Cocensys Inc Irvine | Neuroactive steroids of the androstane and pregnane series |
US6780853B1 (en) | 1995-06-06 | 2004-08-24 | Euro-Celtique S.A. | Neuroactive steroids of the androstane and pregnane series |
US5763432A (en) * | 1997-01-29 | 1998-06-09 | Sri International | Steriod inhibitors of estrone sulfatase and associated pharmaceutical compositions and methods of use |
CN1187367C (zh) * | 1999-04-29 | 2005-02-02 | 欧洲凯尔特股份有限公司 | 具有麻醉剂活性的3α-羟基-3β-甲氧基甲基-21-杂环取代的类固醇 |
WO2020123855A1 (en) | 2018-12-12 | 2020-06-18 | University Of Washington | Inhibitor compounds for male contraception |
JP2022529745A (ja) * | 2019-04-27 | 2022-06-23 | ヘルス リサーチ インコーポレイテッド | 前立腺癌の治療のためのクマリン修飾アンドロゲン |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS504059A (ja) * | 1972-12-19 | 1975-01-16 |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3052693A (en) * | 1959-03-13 | 1962-09-04 | Schering Ag | Steroid alkyl ethers and process therefor |
US3290293A (en) * | 1961-12-01 | 1966-12-06 | Merck & Co Inc | 4-androsteno-[3, 2-c] pyrazoles |
US3301850A (en) * | 1964-12-01 | 1967-01-31 | Searle & Co | 17-oxygenated-5alpha-androstane-2alpha, 3alpha-episulfides |
US3380886A (en) * | 1965-04-07 | 1968-04-30 | Upjohn Co | 7alpha-methyl-3beta-hydroxy-5-androstenes |
GB1185844A (en) * | 1967-08-08 | 1970-03-25 | Merck & Co Inc | 2',3'alpha-Tetrahydrofuran-2'-Spiro-17-Androstene Compounds |
GB1327910A (en) * | 1971-04-20 | 1973-08-22 | Snytex Corp | 2alpha-methyl-17beta-cyclopentyloxy-5alpha-androstan- 3-one |
US4053489A (en) * | 1971-04-21 | 1977-10-11 | Pierre Charles Wirth | Oestratriene diethers |
DE2439082A1 (de) * | 1974-08-12 | 1976-02-26 | Schering Ag | 17 alpha-hydroxy-1,3,5(10),15-oestratetraene und verfahren zu ihrer herstellung |
FR2285138A1 (fr) * | 1974-09-20 | 1976-04-16 | Roussel Uclaf | Nouveau derive steroide trienique, son procede de preparation et son application comme medicament |
US3980638A (en) * | 1974-09-20 | 1976-09-14 | The Upjohn Company | Testosterone derivatives |
CH606101A5 (ja) * | 1975-01-30 | 1978-10-13 | Ciba Geigy Ag |
-
1978
- 1978-10-10 US US05/949,797 patent/US4297350A/en not_active Expired - Lifetime
-
1979
- 1979-10-02 GB GB7934064A patent/GB2032924B/en not_active Expired
- 1979-10-02 NL NL7907317A patent/NL7907317A/nl not_active Application Discontinuation
- 1979-10-03 DE DE19792940132 patent/DE2940132A1/de not_active Ceased
- 1979-10-04 IT IT26267/79A patent/IT1124568B/it active
- 1979-10-09 FR FR7925102A patent/FR2438663A1/fr active Granted
- 1979-10-10 CH CH911679A patent/CH643565A5/de not_active IP Right Cessation
- 1979-10-11 JP JP13126279A patent/JPS5555200A/ja active Pending
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS504059A (ja) * | 1972-12-19 | 1975-01-16 |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0648501A (ja) * | 1992-06-04 | 1994-02-22 | Chichibu Cement Co Ltd | 有害物処理容器 |
Also Published As
Publication number | Publication date |
---|---|
IT1124568B (it) | 1986-05-07 |
DE2940132A1 (de) | 1980-04-24 |
US4297350A (en) | 1981-10-27 |
IT7926267A0 (it) | 1979-10-04 |
GB2032924B (en) | 1982-12-22 |
FR2438663B1 (ja) | 1983-06-03 |
GB2032924A (en) | 1980-05-14 |
CH643565A5 (de) | 1984-06-15 |
FR2438663A1 (fr) | 1980-05-09 |
NL7907317A (nl) | 1980-04-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPS5589225A (en) | Inflammation preventing medicine composition | |
NZ189378A (en) | 4-amino-5-alkylsulphonyl-ortho-anisamdes and pharmaceutical compositions | |
NZ190784A (en) | Benzofuranyl-piperidines and pharmaceutical compositions | |
IL58076A (en) | Spiro-oxazolidine diones and pharmaceutical compositions containing them | |
JPS54148730A (en) | Mildewwkilling acylanilide derivative*its manufacture and composition containing it | |
ZA796465B (en) | Compounds and compositions | |
JPS54148734A (en) | Nnhaloacetylphenylaminocarbonyloxime*its manufacture and composition | |
JPS5555200A (en) | Steroid compound and medicine composition | |
JPS5544898A (en) | Compound material containing polyfluovinylidene and its preparation | |
GB2022601B (en) | Sulphonato-organosilanol compounds and compositions | |
JPS559074A (en) | Compound and drug composition | |
JPS5535089A (en) | Penamm1*11dioxide and its composition | |
JPS557285A (en) | Lactam compound and medical composition | |
NZ189899A (en) | Dilignols and dilignol-type compounds pharmaceutical compositions | |
JPS54128555A (en) | Nnphenylalanine derivative*its manufacture and medicine | |
JPS5517385A (en) | Benzimidazolinone derivative and medical composition containing it | |
JPS5533467A (en) | 11phenyll11propanol derivative*its manufacture and medicine containing it | |
JPS5585599A (en) | Steroid compound and its synthesis | |
JPS5535086A (en) | Thazine derivative and medical composition | |
JPS5555155A (en) | 66methoxyy22acetylnaphthaleneoxime derivative*its manufacture and medical composition | |
NZ189279A (en) | Arylaminoimidazolines and pharmaceutical compositions | |
JPS552698A (en) | Thienooor furopyridone derivative* its manufacture and therapeutic composition containing it | |
NZ190293A (en) | Benzimidoyl-piperazines and pharmaceutical compositions | |
IL57882A0 (en) | 2-thiophenecarboxamido-alkylmercaptans and pharmaceutical compositions containing them | |
JPS54109958A (en) | Steroid compound and its manufacture |